FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

16050611000001101: Flucloxacillin 250mg capsules (Bristol Laboratories Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Nov 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
56622601000001117 Flucloxacillin 250mg capsules (Bristol Laboratories Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
56622701000001110 Flucloxacillin 250mg capsules (Bristol Laboratories Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Flucloxacillin 250mg capsules (Bristol Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Flucloxacillin 250mg capsules (Bristol Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Flucloxacillin 250mg capsules (Bristol Laboratories Ltd) Is a Flucloxacillin 250mg capsules true Inferred relationship Existential restriction modifier
Flucloxacillin 250mg capsules (Bristol Laboratories Ltd) Is a Flucloxacillin 250mg capsules false Inferred relationship Existential restriction modifier
Flucloxacillin 250mg capsules (Bristol Laboratories Ltd) Is a Product containing precisely flucloxacillin 250 milligram/1 each conventional release oral capsule false Inferred relationship Existential restriction modifier
Flucloxacillin 250mg capsules (Bristol Laboratories Ltd) Has active ingredient Flucloxacillin false Inferred relationship Existential restriction modifier
Flucloxacillin 250mg capsules (Bristol Laboratories Ltd) Has manufactured dose form Conventional release oral capsule true Inferred relationship Existential restriction modifier
Flucloxacillin 250mg capsules (Bristol Laboratories Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Flucloxacillin 250mg capsules (Bristol Laboratories Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Flucloxacillin 250mg capsules (Bristol Laboratories Ltd) Has specific active ingredient Flucloxacillin sodium true Inferred relationship Existential restriction modifier
Flucloxacillin 250mg capsules (Bristol Laboratories Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Flucloxacillin 250mg capsules (Bristol Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Flucloxacillin true Inferred relationship Existential restriction modifier
Flucloxacillin 250mg capsules (Bristol Laboratories Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Flucloxacillin 250mg capsules (Bristol Laboratories Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Flucloxacillin 250mg capsules (Bristol Laboratories Ltd) Has basis of strength substance Flucloxacillin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Flucloxacillin 250mg capsules (Bristol Laboratories Ltd) 28 capsule 2 x 14 capsules Has AMP True Flucloxacillin 250mg capsules (Bristol Laboratories Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start